UNRESECTABLE HER2-LOW BREAST CARCINOMA

Clinical trials for UNRESECTABLE HER2-LOW BREAST CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE HER2-LOW BREAST CARCINOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE HER2-LOW BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists test novel drug duo in fight against Tough-to-Treat cancers

Disease control Recruiting now

This early-phase study aims to find a safe and tolerable dose of a new drug combination for people with advanced breast cancer and other solid tumors that have a protein called HER2. The trial will test pidnarulex, which aims to stop tumor cell growth, together with an existing t…

Matched conditions: UNRESECTABLE HER2-LOW BREAST CARCINOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

UNRESECTABLE HER2-LOW BREAST CARCINOMA

Get alerted when new UNRESECTABLE HER2-LOW BREAST CARCINOMA trials appear

Scientists test novel drug duo in fight against Tough-to-Treat cancers